Kotak India Private Equity Fund III

India Health

Kotak India Private Equity Fund III focuses on investments in mid-sized high-growth firms in the pharmaceutical, life sciences, healthcare, consumer, technology and financial services sectors.

Our investment

In 2016, CDC invested $40 million in Kotak India Private Equity Fund III. Our investment provides much-needed growth capital for India's mid-sized firms in the healthcare sectors.

Expected impact

Many of India's small and medium-sized businesses struggle to raise the finance they need to expand beyond their local markets.

Our investment enables the fund manager to invest in Indian entrepreneurs and teams at emerging businesses which have the potential for regional or national growth.

This helps foster the country’s next generation of successful enterprises, create direct and indirect jobs, and generate broader economic growth.

In addition to growth capital, the fund manager provides managerial, technical and operational know-how to investee companies.

Predecessor funds have invested in healthcare provider Manipal Hospitals, pharmaceutical company Rubicon, and aerospace manufacturer, Mahindra Aerospace.

Environmental and social aspects

We work closely with the fund manager to improve its existing Environmental and Social Management System, including delivering an action plan.

Key facts


Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.

South Asia

We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people. For funds, the sectors listed here are those the fund has invested in so far.

Investment type

We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).

Intermediated investment
Fund manager:
Kotak Mahindra (International) Limited
Start date

For direct investments, this is the date CDC committed capital to the business or project.

For funds, this is the date that CDC committed capital to the fund.

For underlying fund investments, this is the date that the fund invested capital into the business.e

March 2016

For direct investments, this is the total amount that CDC has committed to the business or project (it may be a combination of equity and debt).

For funds, this is the total amount that CDC has committed to the fund.


This is the investee company’s place of incorporation; or a fund’s jurisdiction.


Investments made by this fund

  • Active
  • Exited
Investment name Country Region Sector Start date Status
Bharat Serums & Vaccines Limited

Bharat Serums & Vaccines manufacture and market bio-pharmaceuticals in India.

View investment details

India South Asia Health August 2016 Exited

Subscribe to hear more from us